Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Evan Sisson, notes that, even in the recent past, drug therapy was frequently “one-size-fits-all.” But now, newer agents are coming out that target other matebolic places which can affect LDL cholesterol in many different ways. As the medical community learns more about these other mechanisms, more tailored treatments may become possible, reducing residual risk. Sisson is optimistic with the sense that we haven’t been moving very much in this area of therapy for a while and suddenly, there seem to be some promising agents on the horizon.
More videos with Evan Sisson:
Evan Sisson, PharmD, MHA, CDE, Introduction
Evan Sisson, PharmD, Q1: What Are the Current Guidelines on Lipid Treatment?
Evan Sisson, PharmD, Q2: How Has the Definition of the “Right” Level for LDL Changed?
Evan Sisson, PharmD, Q3: What LDL Level Should Patients Aim For?
Evan Sisson, PharmD, Q4: What Is the Best LDL?
Evan Sisson, PharmD, Q5: Should We Just Add Statins to Our Drinking Water?
Evan Sisson, PharmD, Q7: How Can Lifestyle Affect Statin Use?
Evan Sisson, PharmD, MHA, CDE, is currently an assistant professor at the Virginia Commonwealth University’s School of Pharmacy where he teaches pharmacy, nursing and medical students about drug therapy for hypertension, dyslipidemia and diabetes. His practice settings include a university-based outpatient pharmacotherapy clinic and a local free clinic. In the free clinic, he regularly conducts diabetes education classes.
Sisson is a frequent author. One article was Dyslipidemias: Therapeutic Advances, which appeared in the ACCP Pharmacotherapy Self-Assessment Program used by clinical pharmacists to maintain board certification. Additionally, he authored two AADE publications including AADE’s Quick Guide to Medications and The Diabetes Education Review Guide.
Sisson is very active on the volunteer front. In addition to recently serving on AADE’s Board of Directors, he is a member of Diabetes Forecast magazine’s editorial board and recently served on the National Health Council’s Advisory Board on Patient-Centered Care.
Sisson earned his PharmD and MHA degrees from Virginia Commonwealth University.